Unapproved peptides ‘pose growing public health risk’


Health leaders voice concerns over increased availability, promotion and use of unapproved peptides  Australians are being urged to steer clear of peptide products that are not listed on the Australian Register of Therapeutic Goods (ARTG), with experts raising safety concerns.  In a joint statement, the Therapeutic Goods Administration (TGA) and the Chief Medical Officer, Professor

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Opioid use down amid tighter scripts
Next Indexation ‘a minimum’ for pharmacy programs